AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy
Source: dicardiology.com
Stay updated with breaking news from Lothar Roessig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy